CLSI I/LA28-A2 (R2018) PDF

CLSI I/LA28-A2 (R2018) PDF

Name:
CLSI I/LA28-A2 (R2018) PDF

Published Date:
01/01/2011

Status:
Active

Description:

Quality Assurance for Design Control and Implementation of Immunohistochemistry Assays; Approved Guideline-Second Edition, ILA28A2E

Publisher:
Clinical and Laboratory Standards Institute

Document status:
Active

Format:
Electronic (PDF)

Delivery time:
10 minutes

Delivery time (for Czech version):
200 business days

SKU:
clsi-i-la28-a2-r2018_1767346

Choose Document Language:
54.00 €
Need Help?
Immunohistochemistry is an analytical technique that applies an antibody reagent to detect and visualize an antigen in cytological and surgical pathology microscopy specimens in the context of histomorphology and cytomorphology. The clinical-pathological interpretation of the presence and patterns of the antibody-antigen reactions is performed in a manner similar to other molecular pathology assays. Immunohistochemistry is used in diagnostic pathology for diagnosis, determination of prognosis, and predictive assays for response to therapy. Accurate and reproducible results require quality assurance of the total test system including the design control of the reagents and the preexamination (preanalytical), examination (analytical), and postexamination (postanalytical) interpretation steps (processes) of the assay to ensure its clinical applicability. This guideline focuses on validation of immunohistochemistry assays on formalin-fixed, paraffin-embedded pathology material. The audience for this guideline includes the assay developer, the reagent supplier, laboratory histotechnologist who performs the assay, and the laboratory director/pathologist who implements and interprets the assay.
File Size : 1 file , 2.4 MB
ISBN(s) : 1562387456
Note : This product is unavailable in Russia, Belarus
Number of Pages : 156
Published : 01/01/2011

History

CLSI I/LA28-A2 (R2018)
Published Date: 01/01/2011
Quality Assurance for Design Control and Implementation of Immunohistochemistry Assays; Approved Guideline-Second Edition, ILA28A2E
54.00 €
CLSI MM04-A
Published Date: 12/01/1999
Quality Assurance for Immunocytochemistry; Approved Guideline, MM04A

Related products

CLSI NBS06-A
Published Date: 04/01/2013
Newborn Blood Spot Screening for Severe Combined Immunodeficiency by Measurement of T-cell Receptor Excision Circles; Approved Guideline, NBS06AE
54.00 €
CLSI NBS05
Published Date: 12/01/2019
Newborn Screening for Cystic Fibrosis, 2nd Edition, NBS05Ed2E
54.00 €
CLSI QMS12
Published Date: 03/29/2019
Developing and Using Quality Indicators for Laboratory Improvement, 2nd Edition, QMS12Ed2E
54.00 €

Best-Selling Products